🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Solid Tumor, Unspecified, Adult

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values NCT04942717NA5 sites📍 New York📍 New York📍 The Bronx Memorial Sloan Kettering Cancer Center · Tests: CONVO intervention Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors NCT04643418Phase 1, Phase 21 site📍 Taipei MegaPro Biomedical Co. Ltd. · Tests: MPB-1734 Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors NCT02215928n/a1 site📍 Palo Alto Stanford University · Tests: mutation analysis, cytology specimen collection procedure, laboratory biomarker analysis Gustave Roussy Cancer Profiling NCT04932525NA4 sites📍 Villejuif📍 Le Plessis-Robinson📍 Paris Gustave Roussy, Cancer Campus, Grand Paris · Tests: Biopsy A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539Phase 12 sites📍 Taichung📍 Tainan LaunXP Biomedical Co., Ltd. · Tests: LXP1788 is administered intravenously via Port-A Copenhagen Prospective Personalized Oncology (CoPPO) NCT02290522NA1 site📍 Copenhagen Ulrik Lassen · Tests: Tumor biopsy Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI NCT04954599Phase 1, Phase 25 sites📍 Brussels📍 Ghent📍 Maastricht Maastricht University Medical Center · Tests: CP-506, Carboplatin, Immune checkpoint inhibitor Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment NCT05695638n/a1 site📍 Aalborg Morten Ladekarl Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors NCT00900471n/a1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: biologic sample preservation procedure, medical chart review AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors NCT06911333Phase 1, Phase 23 sites📍 Seongnam-si📍 Seoul📍 Seoul Avelos Therapeutics Inc. · Tests: AD1208 Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants NCT00992303n/a1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: biologic sample preservation procedure, medical chart review, questionnaire administration An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors NCT04443088Phase 13 sites📍 Lafayette📍 San Antonio📍 San Antonio Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-1120, Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy